Facebook Pixel Code

Sanjivani paranteral Share Price

NSE
BSE

SANJIVANI PARANTERAL

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Sanjivani paranteral along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹210.50 Closed
-0.38₹ -0.8
As on Oct 31, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Sanjivani paranteral Price Performance

Today's LowToday's High
₹207.00₹214.00
₹210.50
52 Weeks' Low52 Weeks' High
₹193.00₹396.95
₹210.50
Open Price
₹210.25
Prev. Close
₹211.30
Volume
2,990

Over the last 5 years, the share price of Sanjivani paranteral has gained 86.70% CAGR. Over the past year, the corresponding return has been -32.81%.

Sanjivani paranteral’s current P/E of 31.88x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Sanjivani paranteral Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Sanjivani paranteral
5.57-4.27-3.64-11.11-32.8159.9486.70
Sun Pharmaceutical Industries
-0.573.28-0.92-7.60-8.6118.4829.21
Divi's Laboratories
2.6518.412.4510.8514.7323.3117.28
Cipla
-5.18-0.81-3.38-1.58-3.328.7914.87
Torrent Pharmaceuticals
-0.80-0.38-5.149.0110.8529.1022.78
Dr. Reddy's Laboratories
-6.61-3.78-5.651.37-5.9010.604.30
Mankind Pharma
-2.15-2.43-7.34-0.11-10.7718.6610.81
Zydus Lifesciences
-3.15-1.790.4110.00-2.7830.9518.88
Lupin
1.95-0.642.09-4.31-9.9341.2716.64
Aurobindo Pharma
4.934.74-0.20-6.06-18.4328.368.42
Alkem Laboratories
-0.730.839.428.53-4.8120.3915.68
Abbott India
-3.15-2.92-15.75-5.700.0814.6213.33
Glenmark Pharmaceuticals
3.96-3.48-11.3837.4311.6567.2131.92
Laurus Labs
3.169.459.1853.8694.0428.0525.98
Biocon
3.587.36-4.8816.7417.6711.37-1.64
GlaxoSmithKline Pharmaceuticals
-4.58-2.61-16.91-8.00-3.5123.9713.24
Anthem Biosciences
-1.31-7.94-6.37-2.73-2.73-0.92-0.55
Ipca Laboratories
0.17-4.35-13.80-7.87-20.0211.982.00
Gland Pharma
-0.60-2.66-6.6637.2516.792.611.15
Ajanta Pharma
2.222.85-10.32-4.54-19.6923.8618.63

Over the last one year, Sanjivani paranteral has declined 32.81% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Sanjivani paranteral has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).

Sanjivani paranteral Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Sanjivani paranteral Stock Technicals

Moving Average

DaySMAEMA
5202.67205.6
10205.44206.57
20212.62211.56
50227220.34
100225.55227.93
200248.77238.01

Sanjivani paranteral Share Holding Pattern

In the latest quarter, Sanjivani paranteral remained same as its previous close in promoter holding, while DII stake unchanged at 6.02%, FII holding unchanged at 0.00%, and public shareholding unchanged at 62.77% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Sanjivani paranteral Corporate Actions

Date Time
Announcement
Oct 16, 2025, 12:27 AM ISTSanjivani parant - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 09, 2025, 12:34 AM ISTSanjivani parant - Announcement under Regulation 30 (LODR)-Dividend Updates
Sep 27, 2025, 8:12 PM ISTSanjivani parant - Announcement under Regulation 30 (LODR)-Change in Management
Sep 27, 2025, 8:00 PM ISTSanjivani parant - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 26, 2025, 11:37 PM ISTSanjivani parant - Shareholder Meeting / Postal Ballot-Outcome of AGM

About Sanjivani paranteral

Sanjivani paranteral Ltd. is a Public Limited Listed company incorporated on 05/10/1994 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24300MH1994PLC081752 and registration number is 081752. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 70.10 Cr. and Equity Capital is Rs. 11.88 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Ashwani Khemka
    Chairman & Managing Director
  • Mrs. Mrunmai Sarvankar
    Ind. Non-Executive Director
  • Mr. Srivardhan Khemka
    Executive Director
  • Mrs. Monika A Singhani
    Ind. Non-Executive Director
  • Mr. Abhay Shah
    Ind. Non-Executive Director

FAQs on Sanjivani paranteral Share Price

What is the share price of Sanjivani paranteral?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sanjivani paranteral is ₹210.50 as on Oct 31, 2025.

What kind of stock is Sanjivani paranteral?

The Sanjivani paranteral is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Sanjivani paranteral?

The market cap of Sanjivani paranteral is ₹258.58 Cr as on Oct 31, 2025.

What are today's High and Low prices of Sanjivani paranteral?

Today’s highest and lowest price of Sanjivani paranteral are ₹214.00 and ₹207.00.

What are the 52 Week High and 52 Week Low of Sanjivani paranteral?

The 52-week high/low is the highest and lowest price at which Sanjivani paranteral stock has traded in the past 52-week or nearly a year. The 52-week high of Sanjivani paranteral is ₹396.95 and 52-week low of Sanjivani paranteral is ₹193.00 as on Oct 31, 2025.

How has the Sanjivani paranteral performed historically in terms of returns?

The Sanjivani paranteral has shown returns of -0.38% over the past day, -4.27% for the past month, -3.64% over 3 months, -32.81% over 1 year, 59.94% across 3 years, and 86.7% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Sanjivani paranteral?

P/E ratio of and PB ratio of Sanjivani paranteral are 31.88 and 6.73 on Oct 31, 2025. While the company gives a dividend yield of 0.24 per annum.

Sanjivani paranteral News

icon
Market Pulse